'We're Fighting a War of Information': Dr. Pierre Kory
Doctors who have developed effective protocols treating COVID-19 patients have difficulty getting their voices heard because information has been suppressed
Stay updated with breaking news from Guidelines Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Doctors who have developed effective protocols treating COVID-19 patients have difficulty getting their voices heard because information has been suppressed
The U.S. Food and Drug Administration (FDA) announced Jan. 24 it is restricting the use of two monoclonal ...
(The Center Square) – The Food and Drug Administration announced Monday evening that effective immediately, certain monoclonal antibodies would no longer be available to states and health-care providers, saying they
Bamlanivimab/etesevimab and casirivimab/imdevimab are highly unlikely to be active against the Omicron variant, which now makes up virtually all cases of COVID-19 in the United States, the FDA says.
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero